Ardeleanu, Marius

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 2,110

Conjunctivitis in dupilumab clinical trials

Akinlade, B., Guttman‐Yassky, E., Bruin‐Weller, M., Simpson, E. L., Blauvelt, A., Cork, M. J., Prens, E., Asbell, P., Akpek, E., Corren, J., et al. (2019) · British Journal of Dermatology

Dermatology and Skin DiseasesOcular Surface and Contact Lens

Cited by 442

Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

Deleuran, M., Thaçi, D., Beck, L. A., de Bruin-Weller, M., Blauvelt, A., Forman, S., Bissonnette, R., Reich, K., Soong, W., Hussain, I., et al. (2020) · Journal of the American Academy of Dermatology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 255

Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases

Hamilton, J. D., Harel, S., Swanson, B. N., Brian, W., Chen, Z., Rice, M. S., Amin, N., Ardeleanu, M., Radin, A., Shumel, B., et al. (2021) · Clinical & Experimental Allergy

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 192

Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)

Chalmers, J. R., Simpson, E., Apfelbacher, C. J., Thomas, K. S., Kobyletzki, L., Schmitt, J., Singh, J. A., Svensson, Å., Williams, H. C., Abuabara, K., et al. (2016) · British Journal of Dermatology

Dermatology and Skin DiseasesDelphi Technique in Research

Cited by 125

Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma

Bansal, A., Simpson, E. L., Paller, A. S., Siegfried, E. C., Blauvelt, A., de Bruin-Weller, M., Corren, J., Sher, L., Guttman-Yassky, E., Chen, Z., et al. (2021) · American Journal of Clinical Dermatology

Dermatology and Skin DiseasesOcular Surface and Contact Lens

Cited by 52

The safety data of Dupilumab for the treatment of moderate-to-severe atopic dermatitis in infants, children, adolescents, and adults

Langley, R. G., Gherardi, G., Coleman, A., Ardeleanu, M., Rodríguez-Marco, A., Levy, S., Bansal, A., Chen, Z., Rossi, A. B., Shumel, B., et al. (2025) · American Journal of Clinical Dermatology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 18